Literature DB >> 9166284

Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.

C Gilles1, M Polette, M Seiki, P Birembaut, E W Thompson.   

Abstract

We have previously demonstrated that fibroblasts and invasive human breast carcinoma (HBC) cells specifically activate matrix metalloproteinase-2 (MMP-2) when cultured on 3-dimensional gels of type I collagen but not a range of other substrates. We show here the constitutive expression of membrane-type 1 (MT1)-MMP in both fibroblasts, and invasive HBC cell lines, that have fibroblastic attributes presumably acquired through an epithelial-to-mesenchymal transition (EMT). Treatment with collagen type I increased the steady-state MT1-MMP mRNA levels in these cells but did not induce either MT1-MMP expression or MMP-2 activation in noninvasive breast carcinoma cell lines, which retain epithelial features. Basal MT3-MMP mRNA expression had a pattern similar to that of MT1-MMP but was not up-regulated by collagen. MT4-MMP mRNA was seen in both invasive and noninvasive HBC cell lines and was also not collagen-regulated, and MT2-MMP mRNA was not detected in any of the HBC cell lines tested. These data support a role for MT1-MMP in the collagen-induced MMP-2-activation seen in these cells. In situ hybridization analysis of archival breast cancer specimens revealed a close parallel in expression of both collagen type I and MT1-MMP mRNA in peritumoral fibroblasts, which was correlated with aggressiveness of the lesion. Relatively high levels of expression of both mRNA species were seen in fibroblasts close to invasive tumor nests and, although only focally, in certain areas close to preinvasive tumors. These foci may represent hot spots for local degradation and invasive progression. Collectively, these results implicate MT1-MMP in collagen-stimulated MMP-2 activation and suggest that this mechanism may be employed in vivo by both tumor-associated fibroblasts and EMT-derived carcinoma cells to facilitate increased invasion and/or metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166284

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  42 in total

1.  Regulation of reactionary dentin formation by odontoblasts in response to polymicrobial invasion of dentin matrix.

Authors:  Nattida Charadram; Ramin M Farahani; Derek Harty; Catherine Rathsam; Michael V Swain; Neil Hunter
Journal:  Bone       Date:  2011-11-04       Impact factor: 4.398

2.  Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration.

Authors:  Elisabeth L Bair; Man Ling Chen; Kathy McDaniel; Kiyotoshi Sekiguchi; Anne E Cress; Raymond B Nagle; George Timothy Bowden
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis.

Authors:  P Liokumovich; I Goldberg; B Davidson; W H Gotlieb; T Zahavi; G Ben-Baruch; I Reder; J Kopolovic
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  Heat shock-mediated transient increase in intracellular 3',5'-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation.

Authors:  Y Sawaji; T Sato; M Seiki; A Ito
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-kappaB and LEF-1.

Authors:  Damian Medici; Ali Nawshad
Journal:  Matrix Biol       Date:  2009-12-16       Impact factor: 11.583

Review 6.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Authors:  Lidiya S Orlichenko; Derek C Radisky
Journal:  Clin Exp Metastasis       Date:  2008-02-20       Impact factor: 5.150

Review 7.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

8.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

9.  Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications.

Authors:  Olga Hartman; Chu Zhang; Elizabeth L Adams; Mary C Farach-Carson; Nicholas J Petrelli; Bruce D Chase; John F Rabolt
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

10.  Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation.

Authors:  Queena Hwang; Sela Cheifetz; Christopher M Overall; Christopher A McCulloch; Jaro Sodek
Journal:  BMC Cancer       Date:  2009-04-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.